Frahm, N., Friedrich, D. P., Walsh, P., De Rosa, S., Spearman, P., Barnett, S., … McElrath, M. J. (2011). A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens. In AIDS RESEARCH AND HUMAN RETROVIRUSES (Vol. 27, pp. A24–A25). Bangkok, THAILAND: MARY ANN LIEBERT INC.

Frahm, N., D. P. Friedrich, P. Walsh, S. De Rosa, P. Spearman, S. Barnett, M. Keefer, et al. “A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens.” In AIDS RESEARCH AND HUMAN RETROVIRUSES, 27:A24–25. MARY ANN LIEBERT INC, 2011.

Frahm N, Friedrich DP, Walsh P, De Rosa S, Spearman P, Barnett S, et al. A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens. In: AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2011. p. A24–5.

Frahm, N., et al. “A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens.” AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 27, no. 10, MARY ANN LIEBERT INC, 2011, pp. A24–25.

Frahm N, Friedrich DP, Walsh P, De Rosa S, Spearman P, Barnett S, Keefer M, Goepfert P, Robinson H, Graham B, Liao H, Tomaras G, Haynes B, Rerks-Ngarm S, Kim J, McElrath MJ. A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens. AIDS RESEARCH AND HUMAN RETROVIRUSES. MARY ANN LIEBERT INC; 2011. p. A24–A25.